Obviously not op, but it sounds like the issue is that the cure makes you sick in the short term which requires expensive care. If the sickness is inherent to the solution it’s hard to see how this gets cheaper.
The next generation CAR-T treatments are supposed to be "easier" on the immune system and hopefully don't require the prolonged hospitalizations. But that is 5-10 years away.